Almotriptan Related Compound A
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

1018676-02-2Almotriptan Related Compound A

● Auf Lager

Katalog-Nr.::VL264001
CAS-Nr.::1018676-02-2
Summenformel::C18H27N3O3S
Molare Masse::365.49 g/mol

Zusätzliche Informationen zu CAS 1018676-02-2

Parent drug

Almotriptan

IUPAC-Name

{3-[2-(dimethylamino)-ethyl]-5-[(pyrrolidin-1-yl-sulfonyl)methyl]-1H-indol-1-yl}- methanol

Synonyme

Almotriptan Related Compound A / Almotriptan Hydroxymethyl Impurity

Beschreibung

Almotriptan Related Compound A or Almotriptan Hydroxymethyl Impurity (CAS No: 1018676-02-2) is an impurity formed during the synthesis of Almotriptan. Almotriptan hydrogen malate is a selective serotonin (5-HT)1B/1D agonist that belongs to the class of second-generation triptans, which is utilized for the acute treatment of the headache phase of migraine attacks.

References

Kumar, A. Phani, et al. “A Validated Reversed Phase HPLC Method for the Determination of Process-Related Impurities in Almotriptan Malate API.” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 4, Mar. 2008, pp. 792–98, https://doi.org/10.1016/j.jpba.2007.11.029. ?Orlandini, S., et al. “An Integrated Quality by Design and Mixture-Process Variable Approach in the Development of a Capillary Electrophoresis Method for the Analysis of Almotriptan and Its Impurities.” Journal of Chroma

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url